Skip to main content
Addgene

pTRIP-SFFV-EGFP-NLS Citations (12)

Originally described in: ESCRT III repairs nuclear envelope ruptures during cell migration to limit DNA damage and cell death.
Raab M, Gentili M, de Belly H, Thiam HR, Vargas P, Jimenez AJ, Lautenschlaeger F, Voituriez R, Lennon-Dumenil AM, Manel N, Piel M Science. 2016 Apr 15;352(6283):359-62. doi: 10.1126/science.aad7611. Epub 2016 Mar 24.
PubMed Journal

Articles Citing pTRIP-SFFV-EGFP-NLS

Articles
Chromatin-bound cGAS is an inhibitor of DNA repair and hence accelerates genome destabilization and cell death. Jiang H, Xue X, Panda S, Kawale A, Hooy RM, Liang F, Sohn J, Sung P, Gekara NO. EMBO J. 2019 Oct 4;38(21):e102718. doi: 10.15252/embj.2019102718. Epub 2019 Sep 23. PubMed
A cell-free antibody engineering platform rapidly generates SARS-CoV-2 neutralizing antibodies. Chen X, Gentili M, Hacohen N, Regev A. bioRxiv. 2020 Oct 30. doi: 10.1101/2020.10.29.361287. PubMed
Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions. Filbin MR, Mehta A, Schneider AM, Kays KR, Guess JR, Gentili M, Fenyves BG, Charland NC, Gonye ALK, Gushterova I, Khanna HK, LaSalle TJ, Lavin-Parsons KM, Lilley BM, Lodenstein CL, Manakongtreecheep K, Margolin JD, McKaig BN, Rojas-Lopez M, Russo BC, Sharma N, Tantivit J, Thomas MF, Gerszten RE, Heimberg GS, Hoover PJ, Lieb DJ, Lin B, Ngo D, Pelka K, Reyes M, Smillie CS, Waghray A, Wood TE, Zajac AS, Jennings LL, Grundberg I, Bhattacharyya RP, Parry BA, Villani AC, Sade-Feldman M, Hacohen N, Goldberg MB. Cell Rep Med. 2021 May 18;2(5):100287. doi: 10.1016/j.xcrm.2021.100287. Epub 2021 May 3. PubMed

Associated Plasmids

SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes. Li Y, Schneider AM, Mehta A, Sade-Feldman M, Kays KR, Gentili M, Charland NC, Gonye AL, Gushterova I, Khanna HK, LaSalle TJ, Lavin-Parsons KM, Lilley BM, Lodenstein CL, Manakongtreecheep K, Margolin JD, McKaig BN, Parry BA, Rojas-Lopez M, Russo BC, Sharma N, Tantivit J, Thomas MF, Regan J, Flynn JP, Villani AC, Hacohen N, Goldberg MB, Filbin MR, Li JZ. J Clin Invest. 2021 Jul 1;131(13). pii: e148635. doi: 10.1172/JCI148635. PubMed
Expression of the Ebola Virus VP24 Protein Compromises the Integrity of the Nuclear Envelope and Induces a Laminopathy-Like Cellular Phenotype. Vidal S, Sanchez-Aparicio M, Seoane R, El Motiam A, Nelson EV, Bouzaher YH, Baz-Martinez M, Garcia-Dorival I, Gonzalo S, Vazquez E, Vidal A, Munoz-Fontela C, Garcia-Sastre A, Rivas C. mBio. 2021 Aug 31;12(4):e0097221. doi: 10.1128/mBio.00972-21. Epub 2021 Jul 6. PubMed
A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies. Chen X, Gentili M, Hacohen N, Regev A. Nat Commun. 2021 Sep 17;12(1):5506. doi: 10.1038/s41467-021-25777-z. PubMed

Associated Plasmids

Nuclear AIM2-Like Receptors Drive Genotoxic Tissue Injury by Inhibiting DNA Repair. Jiang H, Swacha P, Gekara NO. Adv Sci (Weinh). 2021 Nov;8(22):e2102534. doi: 10.1002/advs.202102534. Epub 2021 Oct 18. PubMed
LAP1 supports nuclear adaptability during constrained melanoma cell migration and invasion. Jung-Garcia Y, Maiques O, Monger J, Rodriguez-Hernandez I, Fanshawe B, Domart MC, Renshaw MJ, Marti RM, Matias-Guiu X, Collinson LM, Sanz-Moreno V, Carlton JG. Nat Cell Biol. 2023 Jan;25(1):108-119. doi: 10.1038/s41556-022-01042-3. Epub 2023 Jan 9. PubMed
Nuclear lamin A/C phosphorylation by loss of Androgen Receptor is a global determinant of cancer-associated fibroblast activation. Ghosh S, Isma J, Mazzeo L, Toniolo A, Simon C, Dotto GP. bioRxiv [Preprint]. 2023 Jun 28:2023.06.28.546870. doi: 10.1101/2023.06.28.546870. PubMed
High-throughput deconvolution of 3D organoid dynamics at cellular resolution for cancer pharmacology with Cellos. Mukashyaka P, Kumar P, Mellert DJ, Nicholas S, Noorbakhsh J, Brugiolo M, Courtois ET, Anczukow O, Liu ET, Chuang JH. Nat Commun. 2023 Dec 18;14(1):8406. doi: 10.1038/s41467-023-44162-6. PubMed
Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells. Rosano D, Sofyali E, Dhiman H, Ghirardi C, Ivanoiu D, Heide T, Vingiani A, Bertolotti A, Pruneri G, Canale E, Dewhurst HF, Saha D, Slaven N, Barozzi I, Li T, Zemlyanskiy G, Phillips H, James C, Gyorffy B, Lynn C, Cresswell GD, Rehman F, Noberini R, Bonaldi T, Sottoriva A, Magnani L. Cancer Discov. 2024 May 1;14(5):866-889. doi: 10.1158/2159-8290.CD-23-1161. PubMed
The TP53-activated E3 ligase RNF144B is a tumour suppressor that prevents genomic instability. Abad E, Sandoz J, Romero G, Zadra I, Urgel-Solas J, Borredat P, Kourtis S, Ortet L, Martinez CM, Weghorn D, Sdelci S, Janic A. J Exp Clin Cancer Res. 2024 Apr 29;43(1):127. doi: 10.1186/s13046-024-03045-4. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.